Skip to main content

RENASANT CORP

For the period ended Sep 30, 2026. Filed Nov 4, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 4, 2026

RNST$40.19+0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows (Unaudited)

Nine Months Ended September 30,
20262025
Operating activities
Net income$254,268$102,324
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses25,18496,522
Depreciation, amortization and accretion7,72113,167
Deferred income tax benefit(853)(4,103)
Gain on sale of mortgage servicing rights—(1,467)
Funding of mortgage loans held for sale(1,057,590)(1,220,267)
Proceeds from sales of mortgage loans held for sale1,130,8981,198,088
Gains on sales of mortgage loans held for sale(12,455)(15,086)
Gains on sales of premises and equipment(13)(347)
Stock-based compensation13,90613,527
Income from bank-owned life insurance(12,342)(10,547)
Net change in operating leases4,4347,613
(Increase) decrease in other assets(133,466)3,238
Increase (decrease) in other liabilities129,911(18,278)
Net cash provided by operating activities349,603164,384
Investing activities
Purchases of securities available for sale(738,290)(1,058,969)
Proceeds from sales of securities available for sale—686,485
Proceeds from call/maturities of securities available for sale361,051203,429
Proceeds from call/maturities of securities held to maturity76,88878,918
Proceeds from sale of mortgage servicing rights—9,353
Net increase in loans(638,785)(929,248)
Purchases of premises and equipment(17,530)(30,337)
Proceeds from sales of premises and equipment8151,366
Proceeds from surrender of bank-owned life insurance—56,255
Purchases of FHLB stock(22,932)(18,205)
Proceeds from redemption of FHLB stock16,01512,075
Purchases of FRB stock(91,303)—
Proceeds from redemption of FRB stock233—
Proceeds from sales of other assets13,14912,605
Net cash (paid) received in acquisition of businesses(67,612)261,483
Other, net6,5853,783
Net cash used in investing activities(1,101,716)(711,007)
Financing activities
Net increase in deposits154,788395,159
Net increase in short-term borrowings250,707199,795
Proceeds from the issuance of long-term debt, net of issuance costs295,755—
Repayment of long-term debt(40,000)—
Cash paid for dividends(65,905)(56,578)
Repurchase of shares in connection with stock repurchase program(179,432)—
Net cash provided by financing activities415,913538,376
Net decrease in cash and cash equivalents(336,200)(8,247)
Cash and cash equivalents at beginning of period1,070,7181,092,032
Cash and cash equivalents at end of period$734,518$1,083,785
Nine Months Ended September 30,
20262025
Supplemental disclosures
Cash paid for interest$345,872$324,630
Cash paid for income taxes$38,458$21,281
Noncash transactions:
Transfers of loans to other real estate owned$14,982$4,057
Common stock issued in acquisition of businesses$—$1,050,821
Recognition of operating right-of-use assets and liabilities$8,777$13,282
Contingent consideration and holdbacks recognized in acquisition of business$8,741$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.